| 时间 | 机构 | 级别 | 目标价 |
|---|---|---|---|
| Barrington Research | 大市一致→表现优胜 | <br> | |
| Rodman & Renshaw | 低于大市→大市一致 | <br> | |
| Rodman & Renshaw | 低于大市 | 13→10 | |
| Barrington Research | 大市一致→Underperform | <br> |
| 总收入额对比(单位：百万美元) |
| 财季/年份 | 2012 | 2011 | 2010 |
| Q1 | 11.00 | 12.00 | 17.00 |
| Q2 | 12.00 | 13.00 | 18.00 |
| Q3 | 17.00 | 18.00 | |
| Q4 | 17.00 | 15.00 | |
| 合计 | 23.00 | 59.00 | 68.00 |
| 每股收益对比(单位：美元) |
| 财季/年份 | 2012 | 2011 | 2010 |
| Q1 | 0.15 | 0.11 | |
| Q2 | 0.10 | 0.14 | |
| Q3 | 0.22 | ||
| Q4 | |||
| 合计 | 0.25 | 0.36 | 0.11 |
| 2011-12-15 | DANTZKER DAVID | 买入 | 11.01 |
| 姓名 | 职务 |
| Robert C. Buhrmaster | 董事会主席 |
| Bruce J. Barclay | 总裁, CEO, Director |
| Philip D. Ankeny | CFO, 高级副总裁 |
| Brian L. Robey | 副总裁 - Product Development and Operations |
| Aron B. Anderson Ph.D. | Chief Scientific Officer, 副总裁 |
| Bryan K. Phillips | 副总裁, General Counsel, Secretary |
| Jan M. Webster | 副总裁 - Human Resources |
| Charles W. Olson | 副总裁, General Manager - Cardiovascular |
| Lise W. Duran Ph.D. | 副总裁 - Research |
| Michael J. Shoup | 副总裁 - Quality, Regulatory and Clinical Affairs |
| 0.69 | +0.33 | +91.67% | |
| 7.57 | +0.71 | +10.35% | |
| 13.82 | +0.32 | +2.37% | |
| 12.50 | +0.26 | +2.12% | |
| 13.32 | +0.26 | +1.99% | |
| 4.24 | +0.05 | +1.19% | |
| 25.96 | +0.27 | +1.05% | |
| 85.20 | +0.84 | +1.0% | |
| 4.13 | +0.03 | +0.73% | |
| 3.37 | +0.02 | +0.6% |
